Personal Care Formulation With AHA, BHA, and PHA Exfoliation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing personal care products fail to effectively exfoliate the stratum corneum to promote cell regeneration and improve skin tone, often leaving visible scars and causing discomfort.

Innovation Solution

A personal care formulation combining alpha hydroxy acids, beta hydroxy acids, and polyhydroxy acids, specifically in defined weight ratios, to gently exfoliate the skin and enhance skin smoothness without visible scarring, using ingredients that mitigate stinging and provide anti-inflammatory benefits.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Shape

If traditional exfoliating products are used to remove dead skin cells, then skin smoothness is improved, but visible scars and discomfort are caused

Engineering Contradiction:
Improveskin smoothnessVSAvoidvisible scars and discomfort
Core Design Contradiction:
ShapeVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameters by using a specific combination of alpha hydroxy acids (AHAs), beta hydroxy acids (BHAs), and polyhydroxy acids (PHAs) in defined weight ratios. This parameter change allows effective exfoliation while minimizing harmful effects like scarring and discomfort, as the specific acid combination and ratios provide controlled chemical peeling action.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a composite formulation combining multiple types of acids (AHAs, BHAs, and PHAs) working synergistically. This composite approach enables comprehensive exfoliation benefits while the combined formula mitigates the harmful effects of individual acids, reducing scarring and discomfort through the balancing action of different acid types.

Inventive Principle:
Principle #40Composite materials

2Illumination intensity

If higher concentrations of exfoliating acids are used to enhance cell regeneration, then skin brightness is improved, but stinging and pain sensation increase

Engineering Contradiction:
Improveskin brightnessVSAvoidstinging and pain sensation
Core Design Contradiction:
Illumination intensityVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes the concentration parameters by establishing specific weight ratios between different acid types. The formulation maintains effective brightness-enhancing exfoliation through the synergistic acid combination while controlling the overall刺激性 to minimize stinging and pain, avoiding the need for excessively high concentrations of any single acid.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces soothing and anti-inflammatory agents as intermediary components that mediate between the exfoliating acids and the skin. These intermediary substances reduce the harmful effects of the acids on skin nerves and tissues, allowing higher effective concentrations for brightness while suppressing stinging and pain sensations.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If aggressive exfoliation is applied to remove dead skin buildup, then skin regeneration is accelerated, but skin barrier integrity is compromised

Engineering Contradiction:
Improvecell regeneration rateVSAvoidskin barrier integrity
Core Design Contradiction:
ProductivityVSStrength

Solution Approach 1:

The patent changes the chemical action parameters by using a balanced combination of acid types with different mechanisms. AHAs provide surface exfoliation, BHAs penetrate deeper, and PHAs offer gentle exfoliation with barrier support. This parameter balance accelerates cell regeneration while preserving skin barrier integrity through the coordinated action of different acid mechanisms.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent ensures continuous skin barrier support during the exfoliation process by incorporating ingredients that maintain barrier integrity throughout the treatment. The formulation provides continuous beneficial action by combining exfoliation with barrier reinforcement, allowing accelerated regeneration without compromising the protective skin barrier function.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulation achieves smoother, more even-toned skin with a glowing appearance by enhancing cell regeneration and fortifying the skin barrier, while minimizing discomfort and scarring.

Implementation Method 1

The present personal care formulations will not leave any visible scars after their application. In some embodiments, the personal care formulations, of the invention are referred to as exfoliating formulations and/or chemical peels.

Methodology Applied
Scientific EffectChemical exfoliation: Hydrolysis

Implementation Method 2

In addition, the personal care formulations include materials that mitigate stinging, pain are anti-inflammatory and soothing.

Methodology Applied
Scientific EffectAnti-inflammatory action:

Data Source

PatentUS12453684B2Personal care formulations
Publication Date: 2025.10.28 COLGATE PALMOLIVE CO
  • US12453684B2 patent drawing
  • US12453684B2 patent drawing
  • US12453684B2 patent drawing

AI summary

Personal care compositions for improving the appearance and/or health of skin are provided herein. In accordance with an aspect, provided is a personal care formulation comprising an alpha hydroxy acid; a beta hydroxy acid; and polyhydroxy acid comprising gluconodeltalactone. According to another aspect, a personal care formulation is provided that comprises an alpha hydroxy acid; a beta hydroxy acid; and polyhydroxy acid, wherein the personal care formulation has a weight ratio of alpha hydroxy acid to polyhydroxy acid is about 5:1 to about 1:4, and wherein the personal care formulation has a weight ratio of beta hydroxy acid to polyhydroxy acid is about 1:1 to about 1:11.